查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1541479

2024-2032 年肠溶软胶囊市场报告（按类型、应用、配销通路和地区）

Enteric Softgel Capsules Market Report by Type, Application, Distribution Channel, and Region 2024-2032
出版日期: | 出版商: IMARC | 英文 144 Pages | 商品交期: 2-3个工作天内

价格

IMARC Group年，全球肠溶软胶囊市场规模达26亿美元。这个市场主要由全球老年人口不断增长、慢性疾病和营养缺乏性疾病患病率上升以及对营养和膳食补充剂的接受度不断提高所推动。

肠溶软胶囊市场分析：

主要市场驱动因素：日益增长的老年人口，更容易受到胃肠道疾病的影响，正在推动肠溶软胶囊的需求。另一个重要的驱动因素是人们对营养保健品和膳食补充剂的偏好不断增加，这些保健品和膳食补充剂需要有针对性地输送到肠道以获得最佳吸收和有效性。

主要市场趋势：市场的一个主要趋势是越来越关注先进的药物输送系统。製药公司正在投资研发，以创造更有效率、更有效的肠溶衣，可以精确控制活性成分的释放。

地理趋势：北美和欧洲由于其完善的医疗基础设施、胃肠道疾病的高盛行率以及对药物研发的大量投资，在肠溶软胶囊市场份额中占据主导地位。

竞争格局：肠溶软胶囊产业的一些主要市场参与者包括Aenova Group GmbH、BASF SE、Catalent, Inc.、Colorcon Inc.、Fuji Capsule Co., Ltd.、Lonza Group AG、Now Health Group, Inc.。 、ProCaps Group、Super Spectrim 和Thermo Fisher Scientific, Inc. 等。他们专注于策略合作、合併和收购，以加强其市场地位并扩大其产品组合。

挑战与机会：根据肠溶软胶囊市场概况，主要挑战之一是严格的监管环境，因为确保遵守不同的法规对製造商来说可能是复杂且成本高昂的。然而，人们越来越认识到肠溶软胶囊在提高药物生物利用度和患者依从性方面的益处，这为市场成长开闢了新的途径。

肠溶软胶囊市场趋势：

慢性病盛行率不断上升

肠溶软胶囊市场的成长主要受到糖尿病、心血管疾病和胃肠道疾病等慢性病盛行率上升的显着推动。根据美国疾病管制与预防中心的数据，估计美国有 1.29 亿人患有至少一种主要慢性疾病，包括心臟病、癌症、糖尿病、肥胖和高血压。此外，美国十大死因中有五个是可预防和可治疗的慢性病，​​或与可预防和可治疗的慢性病密切相关。此外，在过去二十年中，盛行率稳定上升，并且预计这种趋势将持续下去。肠溶软胶囊可连续、有针对性地释放药物，这有利于治疗通常需要长期治疗的疾病。这些胶囊透过在肠道而不是胃中释放其内容物，确保药物在最有效的地方被吸收。这种有针对性的给药是治疗慢性疾病的理想替代方案，因为它可以增强治疗效果并减少副作用。随着人口老化、久坐的生活方式和不断变化的饮食习惯加剧了全球慢性疾病的负担，对肠溶软胶囊和其他复杂的药物输送技术的需求可能会越来越大。

人们越来越偏爱营养补充剂

推动肠溶软胶囊市场收入的另一个因素是消费者对膳食补充剂的兴趣日益增长。根据国家医学图书馆的数据，全球营养保健品和补充剂市场在过去十年中稳步增长，据报道2019 年价值3,530 亿美元。以下主题相关的文章：分别是营养保健品或膳食补充品。此外，自2019年11月开始发生的由严重急性呼吸症候群冠状病毒2（SARS-CoV-2）引起的冠状病毒病（COVID-19）大流行导致膳食补充剂和营养保健品的销量在2020年初出现更大增长营养保健品领域广泛使用肠溶软胶囊来提供维生素、矿物质和其他营养补充剂。这些胶囊具有许多优点，包括提高营养吸收和生物利用度、保护脆弱成分免受胃酸的影响，以及提高客户便利性和依从性。随着人们对其健康优势的认识不断增强，越来越多的人将营养补充品纳入日常生活中。这种趋势在老年族群和想要使用补充剂来预防或治疗医疗问题的注重健康的消费者中尤为突出。

老年人口不断增加

增加肠溶软胶囊市场价值的另一个主要方面是老年人口的成长。根据联合国 (UN) 的数据，全球 65 岁及以上人口预计将增加一倍以上，从 2021 年的 7.61 亿增加到 2050 年的 16 亿。老年人经常有特殊的医疗保健需求，例如治疗多种慢性疾病并需要易于吞嚥、胃肠道友善的药物。肠溶软胶囊满足了这些标准，它提供了一种实用且有效的方法来输送处方药和膳食补充剂。这些胶囊的肠溶衣特别有用，因为消化问题在老年族群中更为常见。此外，随着预期寿命的延长和出生率的下降，世界老年人口正在扩大。肠溶软胶囊可以提高药物依从性和治疗效果，是预期由于人口结构转变而需求增加的医疗保健产品之一。

肠溶软胶囊市场区隔：

IMARC Group提供了每个细分市场的主要趋势分析，以及 2024-2032 年全球、区域和国家层面的预测。我们的报告根据类型、应用和配销通路对市场进行了分类。

按类型划分：

明胶胶囊

非明胶软胶囊

明胶胶囊占大部分市场份额

该报告根据类型提供了详细的市场细分和分析。这包括明胶胶囊和非明胶软胶囊。根据该报告，明胶胶囊代表了最大的部分。

根据肠溶胶囊市场预测，明胶胶囊因其卓越的生物相容性和吸收性而受到广泛青睐。明胶源自动物胶原蛋白，是一种易于人体吸收和消化的天然蛋白质。由于其生物相容性，它对于各种消费者来说也是安全的，包括那些胃部敏感或饮食限制的消费者。明胶胶囊也因具有高生物利用度或活性物质有效吸收到血液中的能力而闻名。因此，用于製造软胶囊的明胶需求不断增加。根据国家医学图书馆的数据，2020 年明胶市场规模达到 31.8 亿美元，预计到 2024 年将达到 40.8 亿美元。

按应用划分：

保健品

药品

保健品占业界最大份额

报告还提供了基于应用程式的详细市场细分和分析。这包括保健品和药品。报告显示，保健品占最大的市占率。

市场以保健品为主，主要是因为人们越来越意识到维护整体健康和福祉的价值。根据Research Gate的数据，53.7%的调查参与者根据医生的建议服用膳食补充剂，28.5%的人自行决定服用，15.9%的人在朋友建议后服用； 87.4%的参与者在药局购买补充剂。随着健康产业的发展，越来越多人开始积极关注自己的健康，并寻找有助于增强免疫力、提供重要的营养并预防慢性疾病的补充剂。由于肠溶软胶囊可以保护脆弱成分免受胃酸的影响，从而改善肠道内的吸收和生物利用度，因此它们是这些营养素的一种有吸引力的输送选择。

按配销通路划分：

超级市场和大卖场

药局和药局

网上商店

药房和药局是主要的细分市场

该报告根据配销通路对市场进行了详细的细分和分析。这包括超市和大卖场、药局和药局以及网路商店。报告称，药局和药局是最大的细分市场。

药房和药局在市场上占有重要的市场份额。这些分布广泛且对消费者友善的零售点为处方药和营养补充品提供了实用的销售点。药剂师可以提供专家指导，顾客经常选择从药局购买与健康相关的产品，保证他们的决定是明智的。根据麦肯锡发布的报告，零售连锁店是四种药房类型中最大、最普遍的，占2021 年商店的三分之一和处方收入的约三分之一。个处方药每年比杂货店多出约 50%，杂货店是美国每个零售点第二大处方药分配商。

按地区划分：

北美洲

美国

加拿大

亚太

中国

日本

印度

韩国

澳洲

印尼

其他的

欧洲

德国

法国

英国

义大利

西班牙

俄罗斯

其他的

拉丁美洲

巴西

墨西哥

其他的

中东和非洲

北美市场领先，占据最大的肠溶软胶囊市场份额

该报告还对所有主要区域市场进行了全面分析，其中包括北美（美国和加拿大）；欧洲（德国、法国、英国、义大利、西班牙、俄罗斯等）；亚太地区（中国、日本、印度、韩国、澳洲、印尼等）；拉丁美洲（巴西、墨西哥等）；以及中东和非洲。报告称，北美是肠溶软胶囊最大的区域市场。

在北美创造有利的肠溶软胶囊市场前景的一个重要驱动因素是慢性疾病盛行率的增加。根据美国国家医学图书馆的数据，美国 50 岁及以上的人口将从 2020 年的 1.3725 亿增加到 2050 年的 2.2113 亿，增长 61.11%。到2050年，慢性病患者将从2020年的7152.2万人增加到1.4266万人，增长99.5%。普遍存在。肠溶软胶囊提供药物的标靶和持续释放，这对于经常需要长期治疗的慢性病患者有益。这些胶囊是治疗慢性疾病的建议选择，因为它们可以增强治疗效果并最大限度地减少不良反应。北美的巨大市场份额主要归因于慢性疾病盛行率的上升，这反过来又推动了对高效实用的给药方法的需求。

竞争格局：

市场研究报告也对市场竞争格局进行了全面分析。也提供了所有主要公司的详细资料。该行业的一些主要肠溶软胶囊公司包括 Aenova Group GmbH、BASF SE、Catalent, Inc.、Colorcon Inc.、Fuji Capsule Co., Ltd.、Lonza Group AG、Now Health Group, Inc.、ProCaps Group、 Super Spectrim 和Thermo Fisher Scientific, Inc.

（请注意，这只是关键参与者的部分列表，报告中提供了完整列表。）

根据肠溶软胶囊市场研究报告，主要参与者正在建立策略联盟和合作伙伴关係以加强其地位。他们也透过与学术机构、研究中心和其他製药公司的合作进行创新。这些伙伴关係经常导致技术和资讯的交流以及新产品的共同开发，所有这些都极大地增强了企业的竞争优势。提高产能是肠溶软胶囊产业顶级竞争对手采用的另一个重要策略。企业可以透过投资新生产设施或改造现有生产设施来提高产能并提高营运效率。此外，企业正在进入新兴市场，这些市场对先进医药产品的需求不断上升，这提供了巨大的成长机会。

肠溶软胶囊市场新闻：

2023年10月，赢创推出了一款功能性、即用型口服胶囊，设计用于临床前试验。 EUDRACAP(R) 临床前肠溶胶囊是一种尺寸非常小的 9 小时（5.1 毫米）技术级胶囊，适合通过临床前动物模型的胃肠道。肠溶胶囊使製药公司能够透过减少临床前试验期间的成本、时间和变数来优化药物开发。

2023 年7 月，美国国家医学图书馆发表了一份报告，介绍了一项使用海藻酸钠(SA)、羧甲基淀粉(CMS) 和κ-卡拉胶(κ-C) 作为基质材料形成软胶囊的试验结果。结果表明，κ-C与CMS和SA具有很强的相互作用，并且κ-C的添加大大改善了胶囊壳的机械性能。因此，本研究为製备肠溶软胶囊提供了替代配方。

本报告回答的关键问题

  • 2023年全球肠溶软胶囊市场规模是多少
  • 2024-2032年全球肠溶软胶囊市场的预期成长率是多少
  • COVID-19对全球肠溶软胶囊市场有何影响
  • 推动全球肠溶软胶囊市场的关键因素是什么
  • 全球肠溶软胶囊市场按类型划分是怎样的
  • 根据应用，全球肠溶软胶囊市场的细分如何
  • 基于配销通路，全球肠溶软胶囊市场的细分如何
  • 全球肠溶软胶囊市场的重点区域有哪些
  • 谁是全球肠溶软胶囊市场的主要参与者/公司

本报告回答的关键问题

  • 2023年全球肠溶软胶囊市场规模？ 2024-2032年全球肠溶软胶囊市场的预期成长率为何？
  • COVID-19 对全球肠溶软胶囊市场有何影响？
  • 推动全球肠溶软胶囊市场的关键因素是什么？
  • 全球肠溶软胶囊市场按类型划分是怎样的？
  • 根据应用，全球肠溶软胶囊市场的细分如何？
  • 基于配销通路，全球肠溶软胶囊市场的细分如何？
  • 全球肠溶软胶囊市场的关键区域有哪些？
  • 全球肠溶软胶囊市场的主要参与者/公司有哪些？

目录

第一章：前言

第 2 章：范围与方法

  • 研究目的
  • 利害关係人
  • 数据来源
    • 主要来源
    • 二手资料
  • 市场预测
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第 3 章：执行摘要

第 4 章：简介

  • 概述
  • 主要行业趋势

第 5 章：全球肠溶软胶囊市场

  • 市场概况
  • 市场表现
  • COVID-19 的影响
  • 市场预测

第 6 章：市场区隔：按类型

  • 明胶胶囊
    • 市场趋势
    • 市场预测
  • 非明胶软胶囊
    • 市场趋势
    • 市场预测

第 7 章：市场区隔：按应用

  • 保健品
    • 市场趋势
    • 市场预测
  • 药品
    • 市场趋势
    • 市场预测

第 8 章：市场区隔：按配销通路

  • 超级市场和大卖场
    • 市场趋势
    • 市场预测
  • 药局和药局
    • 市场趋势
    • 市场预测
  • 网上商店
    • 市场趋势
    • 市场预测

第 9 章：市场区隔：按地区

  • 北美洲
    • 美国
    • 加拿大
  • 亚太
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳洲
    • 印尼
    • 其他的
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙
    • 俄罗斯
    • 其他的
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他的
  • 中东和非洲
    • 市场趋势
    • 市场细分：按国家/地区
    • 市场预测

第 10 章：SWOT 分析

  • 概述
  • 优势
  • 弱点
  • 机会
  • 威胁

第 11 章：价值链分析

第 12 章：波特五力分析

  • 概述
  • 买家的议价能力
  • 供应商的议价能力
  • 竞争程度
  • 新进入者的威胁
  • 替代品的威胁

第 13 章：价格分析

第14章：竞争格局

  • 市场结构
  • 关键参与者
  • 关键参与者简介
    • Aenova Group GmbH
    • BASF SE
    • Catalent, Inc.
    • Colorcon Inc.
    • Fuji Capsule Co., Ltd.
    • Lonza Group AG
    • Now Health Group, Inc.
    • ProCaps Group
    • Super Spectrim
    • Thermo Fisher Scientific, Inc.
Product Code: SR112024A4232

The global enteric softgel capsules market size reached US$ 2.6 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 3.6 Billion by 2032, exhibiting a growth rate (CAGR) of 3.7% during 2024-2032. The market is primarily driven by the growing global geriatric population, the rising prevalence of chronic medical disorders and nutrient-deficient diseases, and the growing acceptance of nutritional and dietary supplements.

Enteric Softgel Capsules Market Analysis:

Major Market Drivers: The growing geriatric population, which is more susceptible to gastrointestinal conditions is boosting the enteric softgel capsule demand. Another significant driver is the rising preference for nutraceuticals and dietary supplements that need targeted delivery to the intestines for optimal absorption and effectiveness.

Key Market Trends: A key trend in the market is the increasing focus on advanced drug delivery systems. Pharmaceutical companies are investing in research and development to create more efficient and effective enteric coatings that can precisely control the release of active ingredients.

Geographical Trends: North America and Europe dominate the enteric softgel capsules market share due to their well-established healthcare infrastructure, high prevalence of gastrointestinal disorders, and significant investment in pharmaceutical research and development.

Competitive Landscape: Some of the major market players in the enteric softgel capsules industry include Aenova Group GmbH, BASF SE, Catalent, Inc., Colorcon Inc., Fuji Capsule Co., Ltd., Lonza Group AG, Now Health Group, Inc., ProCaps Group, Super Spectrim and Thermo Fisher Scientific, Inc. among many others. They are focusing on strategic collaborations, mergers, and acquisitions to strengthen their market position and expand their product portfolios.

Challenges and Opportunities: As per the enteric softgel capsules market overview, one of the main challenges is the stringent regulatory environment as ensuring compliance with varying regulations can be complex and costly for manufacturers. However, the growing awareness of the benefits of enteric softgel capsules in improving drug bioavailability and patient compliance opens new avenues for market growth.

Enteric Softgel Capsules Market Trends:

Growing prevalence of chronic diseases

The enteric softgel capsule market growth is significantly driven by the rising prevalence of chronic diseases like diabetes, cardiovascular disease, and gastrointestinal disorders. As per Centers of Diseases Control and Prevention, an estimated 129 million people in the US have at least 1 major chronic disease including heart disease, cancer, diabetes, obesity, and hypertension. Besides, five of the top 10 leading causes of death in the US are, or are strongly associated with, preventable and treatable chronic diseases. Moreover, over the past two decades prevalence has increased steadily, and this trend is expected to continue. Enteric softgel capsules offer a continuous and targeted release of medication, which is beneficial for treating illnesses that often require long-term treatment. By releasing its contents in the intestines instead of the stomach, these capsules make sure the medication is absorbed where it works best. This targeted administration is a desirable alternative for managing chronic diseases since it can enhance therapeutic outcomes and lessen side effects. With aging populations, sedentary lifestyles, and changing dietary habits contributing to the global burden of chronic diseases, enteric softgel capsules and other sophisticated drug delivery technologies are likely to become more and more in demand.

Increasing preference toward nutritional supplements

Another factor propelling the enteric softgel capsule market revenue is the growing inclination of consumers toward dietary supplements. As per the National Library of Medicine, the global nutraceuticals and supplements market has steadily grown over the past decade and was reported to be worth $353 Billion in 2019. Research in the field has also grown, with over 70,000 published articles available in PubMed relating to nutraceuticals or dietary supplements respectively. Besides, the occurrence of the coronavirus disease (COVID-19) pandemic caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) starting in November 2019 led to an even greater increase in sales of dietary supplements and nutraceuticals in early 2020. The nutraceutical sector uses enteric softgel capsules extensively to provide vitamins, minerals, and other nutritional supplements. These capsules have a number of benefits, including as increased nutrient absorption and bioavailability, shielding delicate components from stomach acids, and improving customer convenience and compliance. More people are including nutritional supplements in their regular routines as awareness of their health advantages develops. This trend is especially prominent among older populations and health-conscious consumers who want to use supplements to prevent or treat medical issues.

Rising geriatric population

Another major aspect increasing the enteric softgel capsule market value is the growing geriatric population. According to the United Nations (UN), the global population aged 65 years or older is expected to be more than double, increasing from 761 million in 2021 to 1.6 billion by 2050. The population aged 80 years or older is growing at an even faster rate. Elderly people frequently have particular healthcare demands, such as managing several chronic illnesses and requiring easy-to-swallow, gastrointestinal-friendly drugs. These criteria are met by enteric softgel capsules, which provide a practical and efficient method of delivering prescription drugs and dietary supplements. These capsules' enteric coating is especially helpful as digestive problems are more common in the elderly population. Additionally, as life expectancy rises and birth rates fall, the world's senior population is expanding. Enteric softgel capsules, which can improve medication adherence and treatment outcomes, are among the healthcare items that are predicted to see an increase in demand as a result of this demographic transition.

Enteric Softgel Capsules Market Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the market, along with forecasts at the global, regional, and country levels for 2024-2032. Our report has categorized the market based on type, application and distribution channel.

Breakup by Type:

Gelatin Capsules

Non-Gelatin Softgel Capsules

Gelatin capsules accounts for the majority of the market share

The report has provided a detailed breakup and analysis of the market based on the type. This includes gelatin capsules and non-gelatin softgel capsules. According to the report, gelatin capsules represented the largest segment.

As per enteric capsules market forecast, gelatin capsules are widely preferred due to their exceptional biocompatibility and absorption. Derived from animal collagen, gelatin is an easily absorbed and digested natural protein by the human body. It is also safe for a variety of consumers including those with sensitive stomachs or dietary restrictions due to its biocompatibility. Gelatin capsules are also renowned for having a high bioavailability, or the ability of the active substances to be effectively absorbed into the bloodstream. Hence, there is an escalating demand for gelatin for manufacturing softgel capsules. As per National Liabrary of Medicine, the market for gelatin in 2020 reached USD 3.18 Billion and is further expected to reach USD 4.08 Billion by 2024 as forecasted in the same report.

Breakup by Application:

Health Supplements

Pharmaceuticals

Health supplements hold the largest share of the industry

A detailed breakup and analysis of the market based on the application have also been provided in the report. This includes health supplements and pharmaceuticals. According to the report, health supplements accounted for the largest market share.

The market is dominated by health supplements primarily due to the increasing awareness of the value of preserving general health and wellbeing. According to the Research Gate, 53.7 % of the participants of the survey took dietary supplements upon the doctor's advice, 28.5 % took them with their own decision, and 15.9 % took them after friend advice; 87.4 % of the participants bought supplements in the pharmacy. As the wellness sector grows, more people are taking an active role in their health and looking for supplements that help boost immunity, deliver vital nutrients, and stave against chronic illnesses. As enteric softgel capsules can shield delicate components from stomach acids, improving absorption and bioavailability in the intestines, they are an appealing delivery option for these nutrients.

Breakup by Distribution Channel:

Supermarkets and Hypermarkets

Pharmacy and Drug Stores

Online Stores

Pharmacy and drug stores represent the leading market segment

The report has provided a detailed breakup and analysis of the market based on the distribution channel. This includes supermarkets and hypermarkets, pharmacy and drug stores, and online stores. According to the report, pharmacy and drug stores represented the largest segment.

Pharmacy and drug stores hold a significant market share in the market. These widely dispersed and consumer-friendly retail locations offer a practical point of sale for prescription drugs and nutritional supplements. Pharmacists can offer expert guidance, customers frequently choose to purchase health-related products from pharmacies, guaranteeing that their decisions are well-informed. As per the report published by Mckinsey, retail chains are the largest and most prevalent of the four pharmacy types, representing a third of stores and about a third of prescription revenues in 2021. On a per-store basis, retail chains dispense approximately 138,000 prescriptions annually about 50 percent more than grocers, the next largest prescription dispensers per retail location in US.

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

North America leads the market, accounting for the largest enteric softgel capsules market share

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America was the largest regional market for enteric softgel capsules.

An important driver creating a favorable enteric softgel capsules market outlook in North America is the increasing prevalence of chronic disorders. As per National Library of Medicine, the number of people in the United States aged 50 years and older will increase by 61.11% from 137.25 million in 2020 to 221.13 million in 2050.Of the population 50 years and older, the number with at least one chronic disease is estimated to increase by 99.5% from 71.522 million in 2020 to 142.66 million by 2050. Owing mostly to aging populations and lifestyle choices, conditions like diabetes, cardiovascular illnesses, and gastrointestinal ailments are prevalent in the area. Enteric softgel capsules provide targeted and sustained release of medications, which is beneficial for patients with chronic conditions who often need long-term treatment. These capsules are a recommended option for managing chronic diseases since they enhance therapeutic outcomes and minimize adverse effects. The substantial market share of North America is mostly attributed to the rising prevalence of chronic illnesses, which in turn drives demand for efficient and practical drug delivery methods.

Competitive Landscape:

The market research report has also provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have also been provided. Some of the major enteric softgel capsules companies in the industry include Aenova Group GmbH, BASF SE, Catalent, Inc., Colorcon Inc., Fuji Capsule Co., Ltd., Lonza Group AG, Now Health Group, Inc., ProCaps Group, Super Spectrim and Thermo Fisher Scientific, Inc.

(Please note that this is only a partial list of the key players, and the complete list is provided in the report.)

As per enteric softgel capsules market research report, key players are establishing strategic alliances and partnerships to strengthen their position. They are also innovating through collaboration with academic institutions, research centers, and other pharmaceutical firms. These partnerships frequently result in the exchange of technology and information as well as the co-development of new goods, all of which greatly strengthen a business's competitive advantage. Increasing production capacity is yet another important tactic used by top competitors in the enteric softgel capsule industry. Businesses can boost production capacity and boost operational efficiency by investing in new production facilities or renovating existing ones. Moreover, companies are entering emerging markets, where the demand for advanced pharmaceutical products is rising, which is providing significant growth opportunities.

Enteric Softgel Capsules Market News:

In October 2023, Evonik launched a functional, ready-to-fill oral capsule designed for use in preclinical trials. EUDRACAP(R) preclinic enteric is a very small size 9h (5.1 mm), technical-grade capsule suitable for passing through the gastrointestinal tract of preclinical animal models. The enteric-coated capsule enables pharmaceutical companies to optimize drug development by reducing cost, time, and variables during preclinical trials.

In July 2023, National Library of Medicine published a report stating results from a trial where sodium alginate (SA), carboxymethyl starch (CMS) and κ-carrageenan (κ-C) were used as matrix materials to form softgel capsules. The results showed that κ-C had strong interaction with CMS and SA, and the mechanical properties of capsule shell were greatly improved by the addition of κ-C. Therefore, the study provided an alternative formula for preparing enteric soft capsules.

Key Questions Answered in This Report

  • 1. What was the size of the global enteric softgel capsules market in 2023?
  • 2. What is the expected growth rate of the global enteric softgel capsules market during 2024-2032?
  • 3. What has been the impact of COVID-19 on the global enteric softgel capsules market?
  • 4. What are the key factors driving the global enteric softgel capsules market?
  • 5. What is the breakup of the global enteric softgel capsules market based on the type?
  • 6. What is the breakup of the global enteric softgel capsules market based on the application?
  • 7. What is the breakup of the global enteric softgel capsules market based on the distribution channel?
  • 8. What are the key regions in the global enteric softgel capsules market?
  • 9. Who are the key players/companies in the global enteric softgel capsules market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Enteric Softgel Capsules Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Type

  • 6.1 Gelatin Capsules
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Non-Gelatin Softgel Capsules
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast

7 Market Breakup by Application

  • 7.1 Health Supplements
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Pharmaceuticals
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast

8 Market Breakup by Distribution Channel

  • 8.1 Supermarkets and Hypermarkets
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Pharmacy and Drug Stores
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Online Stores
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Aenova Group GmbH
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
    • 14.3.2 BASF SE
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
      • 14.3.2.3 Financials
      • 14.3.2.4 SWOT Analysis
    • 14.3.3 Catalent, Inc.
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 Financials
      • 14.3.3.4 SWOT Analysis
    • 14.3.4 Colorcon Inc.
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
    • 14.3.5 Fuji Capsule Co., Ltd.
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
    • 14.3.6 Lonza Group AG
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 Financials
      • 14.3.6.4 SWOT Analysis
    • 14.3.7 Now Health Group, Inc.
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
    • 14.3.8 ProCaps Group
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
    • 14.3.9 Super Spectrim
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
    • 14.3.10 Thermo Fisher Scientific, Inc.
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
      • 14.3.10.3 Financials
      • 14.3.10.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Enteric Softgel Capsules Market: Major Drivers and Challenges
  • Figure 2: Global: Enteric Softgel Capsules Market: Sales Value (in Billion US$), 2018-2023
  • Figure 3: Global: Enteric Softgel Capsules Market Forecast: Sales Value (in Billion US$), 2024-2032
  • Figure 4: Global: Enteric Softgel Capsules Market: Breakup by Type (in %), 2023
  • Figure 5: Global: Enteric Softgel Capsules Market: Breakup by Application (in %), 2023
  • Figure 6: Global: Enteric Softgel Capsules Market: Breakup by Distribution Channel (in %), 2023
  • Figure 7: Global: Enteric Softgel Capsules Market: Breakup by Region (in %), 2023
  • Figure 8: Global: Enteric Softgel Capsules (Gelatin Capsules) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 9: Global: Enteric Softgel Capsules (Gelatin Capsules) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 10: Global: Enteric Softgel Capsules (Non-Gelatin Softgel Capsules) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 11: Global: Enteric Softgel Capsules (Non-Gelatin Softgel Capsules) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 12: Global: Enteric Softgel Capsules (Health Supplements) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 13: Global: Enteric Softgel Capsules (Health Supplements) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 14: Global: Enteric Softgel Capsules (Pharmaceuticals) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 15: Global: Enteric Softgel Capsules (Pharmaceuticals) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 16: Global: Enteric Softgel Capsules (Supermarkets and Hypermarkets) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 17: Global: Enteric Softgel Capsules (Supermarkets and Hypermarkets) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 18: Global: Enteric Softgel Capsules (Pharmacy and Drug Stores) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 19: Global: Enteric Softgel Capsules (Pharmacy and Drug Stores) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 20: Global: Enteric Softgel Capsules (Online Stores) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 21: Global: Enteric Softgel Capsules (Online Stores) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 22: North America: Enteric Softgel Capsules Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 23: North America: Enteric Softgel Capsules Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 24: United States: Enteric Softgel Capsules Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 25: United States: Enteric Softgel Capsules Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 26: Canada: Enteric Softgel Capsules Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 27: Canada: Enteric Softgel Capsules Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 28: Asia-Pacific: Enteric Softgel Capsules Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 29: Asia-Pacific: Enteric Softgel Capsules Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 30: China: Enteric Softgel Capsules Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 31: China: Enteric Softgel Capsules Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 32: Japan: Enteric Softgel Capsules Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 33: Japan: Enteric Softgel Capsules Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 34: India: Enteric Softgel Capsules Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 35: India: Enteric Softgel Capsules Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 36: South Korea: Enteric Softgel Capsules Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 37: South Korea: Enteric Softgel Capsules Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 38: Australia: Enteric Softgel Capsules Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 39: Australia: Enteric Softgel Capsules Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 40: Indonesia: Enteric Softgel Capsules Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 41: Indonesia: Enteric Softgel Capsules Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 42: Others: Enteric Softgel Capsules Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 43: Others: Enteric Softgel Capsules Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 44: Europe: Enteric Softgel Capsules Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 45: Europe: Enteric Softgel Capsules Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 46: Germany: Enteric Softgel Capsules Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 47: Germany: Enteric Softgel Capsules Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 48: France: Enteric Softgel Capsules Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 49: France: Enteric Softgel Capsules Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 50: United Kingdom: Enteric Softgel Capsules Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 51: United Kingdom: Enteric Softgel Capsules Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 52: Italy: Enteric Softgel Capsules Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 53: Italy: Enteric Softgel Capsules Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 54: Spain: Enteric Softgel Capsules Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 55: Spain: Enteric Softgel Capsules Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 56: Russia: Enteric Softgel Capsules Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 57: Russia: Enteric Softgel Capsules Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 58: Others: Enteric Softgel Capsules Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 59: Others: Enteric Softgel Capsules Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 60: Latin America: Enteric Softgel Capsules Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 61: Latin America: Enteric Softgel Capsules Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 62: Brazil: Enteric Softgel Capsules Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 63: Brazil: Enteric Softgel Capsules Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 64: Mexico: Enteric Softgel Capsules Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 65: Mexico: Enteric Softgel Capsules Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 66: Others: Enteric Softgel Capsules Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 67: Others: Enteric Softgel Capsules Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 68: Middle East and Africa: Enteric Softgel Capsules Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 69: Middle East and Africa: Enteric Softgel Capsules Market: Breakup by Country (in %), 2023
  • Figure 70: Middle East and Africa: Enteric Softgel Capsules Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 71: Global: Enteric Softgel Capsules Industry: SWOT Analysis
  • Figure 72: Global: Enteric Softgel Capsules Industry: Value Chain Analysis
  • Figure 73: Global: Enteric Softgel Capsules Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Enteric Softgel Capsules Market: Key Industry Highlights, 2023 and 2032
  • Table 2: Global: Enteric Softgel Capsules Market Forecast: Breakup by Type (in Million US$), 2024-2032
  • Table 3: Global: Enteric Softgel Capsules Market Forecast: Breakup by Application (in Million US$), 2024-2032
  • Table 4: Global: Enteric Softgel Capsules Market Forecast: Breakup by Distribution Channel (in Million US$), 2024-2032
  • Table 5: Global: Enteric Softgel Capsules Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 6: Global: Enteric Softgel Capsules Market: Competitive Structure
  • Table 7: Global: Enteric Softgel Capsules Market: Key Players